Alex Colville, co-founder of Age1, talks about funding longevity science, studying the biology of ageing, the rise of geroscience, healthspan, the potential of metformin, working on an anti-ageing treatment, and how long he thinks we'll live.

Two experts in the longevity industry, Joe Betts-LaCroix and Alex Colville, discuss the past, present, and future of longevity including evaluating founders, societal impacts, and the business case for longevity drugs. They explore challenges in FDA approval, risks in the biotech industry, and misconceptions surrounding longevity.